首页> 外文会议>5th International Photodynamic Association Biennial Meeting >Photodynamic therapy of malignant mesothelioma of pleura
【24h】

Photodynamic therapy of malignant mesothelioma of pleura

机译:恶性胸膜间皮瘤的光动力治疗

获取原文
获取外文期刊封面目录资料

摘要

Abstract: Nine patients with malignant pleural mesothelioma underwent extensive surgery followed by intra-operative photodynamic therapy. Two mg/kg Photofrin was given 48 hours prior to surgery. The thoracic cavity and eventual remaining lung were exposed to 15 - 30 Joules/cm$+2$/ of 630 nm laser light. Tumor tissue was analyzed by microscopic photometrical techniques. Five patients with mixed or epithelioid tumors with fluorescence intensity $GRT 100 gray level/pixel seemed to benefit from the given therapy. One patient was free of disease 18 months after treatment. Two patients were treated for metastasis after 12 months with no sign of intrathoracic recurrence. Both are still alive, one without further sign of disease 32 months after initial treatment. Two patients presented generalized disease after 9 and 13 months and intrathoracic recurrence several months later. Two patients with poorly differentiated tumors and 2 patients with moderate to highly differentiated tumors, but with fluorescence intensity $LS 100 gray level/pixel, presented recurrences after 4 months. PDT-efficiency seems to be predicted by the intensity and distribution of drug-induced fluorescence in tumor tissue. PDT may enhance the possibility to achieve complete local tumor control after excision. Multimodal therapeutic approach of local and systemic disease seems mandatory to further improve survival. !17
机译:摘要:9例恶性胸膜间皮瘤患者接受了广泛的手术,随后进行了术中光动力疗法。术前48小时给予2 mg / kg Photofrin。将胸腔和最终剩余的肺暴露于630 nm激光的15-30焦耳/ cm ++ 2 $ /。通过显微光度技术分析肿瘤组织。五例混合或上皮样肿瘤的荧光强度≥GRT100灰度/像素的患者似乎从给定的治疗中受益。一名患者在治疗18个月后没有疾病。 12个月后有2例患者接受了转移治疗,没有胸腔内复发的迹象。两者都还活着,在初次治疗后32个月没有进一步的疾病迹象。 9个月和13个月后,两名患者出现全身性疾病,几个月后出现胸腔内复发。 2例低分化肿瘤患者和2例中度至高度分化肿瘤,但荧光强度≥LS100灰度/像素的患者在4个月后复发。 PDT的效率似乎可以通过药物诱导的荧光在肿瘤组织中的强度和分布来预测。 PDT可能会增加切除后实现完全局部肿瘤控制的可能性。局部和全身性疾病的多式联运治疗方法似乎是强制性的,以进一步提高生存率。 !17

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号